Solari Domenico, d'Avella Elena, Agresta Gianluca, Catapano Domenico, D'Ecclesia Aurelio, Locatelli Davide, Massimi Luca, Mazzatenta Diego, Spena Giannantonio, Tamburrini Gianpiero, Zoia Cesare, Zoli Matteo, Cinalli Giuseppe, Cappabianca Paolo, Cavallo Luigi Maria
1Department of Neurosciences and Reproductive and Odontostomatological Sciences, Division of Neurosurgery, University of Napoli "Federico II," Naples, Italy.
2Division of Neurosurgery, Università degli Studi dell'Insubria, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.
J Neurosurg. 2022 Jul 8;138(2):522-532. doi: 10.3171/2022.5.JNS212974. Print 2023 Feb 1.
Infradiaphragmatic craniopharyngiomas (ICs) represent a distinct subtype, harboring a sellar-suprasellar origin and generally growing in the extra-arachnoidal space contained by the diaphragma sellae. They have been considered ideal for surgical removal through the transsphenoidal approach since the 1960s. The authors present a multicentric national study, intending to selectively analyze IC behavior and the impact of the transsphenoidal endoscopic endonasal approach (EEA) on surgical outcomes.
Craniopharyngiomas that were intraoperatively recognized as infradiaphragmatic and removed with standard EEA between 2000 and 2021 at 6 Italian neurosurgical departments were included in the study. Clinical, radiological, and surgical findings and outcomes were evaluated and reviewed.
In total, 84 patients were included, with 45.23% identified as pediatric cases and 39.28% as having recurrent tumors. The most common presenting symptoms were endocrine (75%), visual (59.52%), and hypothalamic (26.19%) disorders. ICs were classified as extending below (6 intrasellar and 41 occupying the suprasellar cistern) or above (26 obliterating the anterior recesses of the third ventricle and 11 extending up to the foramina of Monro) the chiasmatic cistern. Gross-total resection (GTR) was achieved in 54 cases (64.28%). Tumor extension above the chiasmatic cistern and calcifications were associated with lower likelihood of GTR. The cumulative rate of postoperative complications was 34.53%, with CSF leak being the most common (14.28%). Endocrine, visual, and hypothalamic functions deteriorated postoperatively in 41/78 patients (52.56%), 5/84 (5.95%), and 14/84 (16.67%), respectively. Twenty-eight patients (33.33%) had recurrence during follow-up (mean 63.51 months), with a mean 5-year progression-free survival (PFS) rate of 58%. PFS was greater in patients who achieved GTR than patients with other extent of resection.
This is the largest series in the literature to describe ICs removed with standard EEA, without the need for additional bone and dural opening over the planum sphenoidale. EEA provides a direct route to ICs, the opportunity to manage lesions extending up to the third ventricle without breaching the diaphragma, and high rates of GTR and satisfactory clinical outcomes. Increased surgical complexity and morbidity should be expected in patients with extensive suprasellar extension and involvement of the surrounding vital neurovascular structures.
膈下颅咽管瘤(ICs)是一种独特的亚型,起源于鞍区-鞍上区,通常生长在鞍隔所包含的蛛网膜下腔空间内。自20世纪60年代以来,它们被认为是经蝶窦入路手术切除的理想对象。作者开展了一项全国多中心研究,旨在选择性分析ICs的行为以及经蝶窦内镜鼻内入路(EEA)对手术结果的影响。
本研究纳入了2000年至2021年间在6个意大利神经外科科室接受标准EEA手术且术中被确认为膈下颅咽管瘤并切除的患者。对临床、影像学、手术发现及结果进行了评估和回顾。
共纳入84例患者,其中45.23%为儿童病例,39.28%为复发性肿瘤。最常见的首发症状为内分泌紊乱(75%)、视觉障碍(59.52%)和下丘脑功能障碍(26.19%)。ICs被分类为延伸至视交叉池下方(6例鞍内型和41例占据鞍上池)或上方(26例闭塞第三脑室前隐窝,11例延伸至室间孔)。54例(64.28%)实现了全切除(GTR)。视交叉池上方的肿瘤延伸和钙化与GTR的可能性较低相关。术后并发症的累积发生率为34.53%,脑脊液漏最为常见(14.28%)。内分泌、视觉和下丘脑功能在术后分别有41/78例患者(52.56%)、5/84例(5.95%)和14/84例(16.67%)恶化。28例患者(33.33%)在随访期间复发(平均63.51个月),5年无进展生存率(PFS)平均为58%。实现GTR的患者的PFS高于其他切除范围的患者。
这是文献中描述采用标准EEA切除ICs的最大系列研究,无需在蝶骨平台上方额外打开骨质和硬脑膜。EEA为ICs提供了一条直接入路,有机会处理延伸至第三脑室的病变而不破坏鞍隔,且GTR率高,临床结果令人满意。对于鞍上广泛延伸且累及周围重要神经血管结构的患者,应预期手术复杂性和发病率会增加。